Search clinical trials for: Relapsed or relapse/refractory Multiple Myeloma
Total 213031 results
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Yanda Ludaopei Hospital; Beijing Lu Daopei HospitalUnknown
-
University Health Network, TorontoMultiple Myeloma Research ConsortiumTerminatedMultiple Myeloma | Relapsed/RefractoryCanada
-
Medical College of WisconsinWithdrawnRefractory Multiple Myeloma | Relapse Multiple Myeloma
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsWithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | HLA-A*0201 Positive Cells Present | NY-ESO-1 Positive Tumor Cells PresentUnited States
-
Celularity IncorporatedCompleted
-
TakedaWithdrawn
-
AmgenTerminatedMultiple MyelomaUnited States, France
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Genzyme, a Sanofi Company; Millennium Pharmaceuticals...CompletedMultiple MyelomaUnited States
-
Hebei Yanda Ludaopei HospitalGracell Biotechnology Ltd.UnknownMultiple MyelomaChina
-
Ajai ChariTerminatedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
CelgeneMultiple Myeloma Research ConsortiumCompleted
-
Cogent Biosciences, Inc.Seagen Inc.TerminatedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Assistance Publique - Hôpitaux de ParisWithdrawn
-
Novartis PharmaceuticalsCompletedMultiple MyelomaChina, United States, Italy, Taiwan, Egypt, Japan, Turkey, Germany, Netherlands, Canada, Australia, Austria, Israel, Sweden, United Kingdom, Korea, Republic of, Spain, Hong Kong, Thailand, France, Belgium, Norway, South Africa, Brazil, ... and more
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma
-
Pharmacyclics Switzerland GmbHJanssen Research & Development, LLCCompletedMultiple MyelomaSpain, Germany, Turkey, Greece, Italy, Czechia
-
Pharmacyclics LLC.CompletedMultiple MyelomaUnited States
-
BayerTerminatedMultiple MyelomaKorea, Republic of, Spain, United States
-
Kosin University Gospel HospitalCompletedRelapsed and/or refractorY Multiple MyelomaKorea, Republic of
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Recurrent Adult Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Non-Hodgkin Lymphoma | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Plasma Cell MyelomaUnited States, Germany, Italy
-
University of LeedsMillennium Pharmaceuticals, Inc.; Myeloma UKUnknown
-
Janssen Research & Development, LLCCompleted
-
University of LeedsCelgene Corporation; Oncolytics Biotech; Myeloma UKUnknownMultiple MyelomaUnited Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.Completed
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma and other conditionsUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieCompletedMultiple MyelomaCzechia, Austria, Germany
-
National Cancer Institute (NCI)Millennium Pharmaceuticals, Inc.Withdrawn
-
The First Affiliated Hospital of Nanchang UniversityUnknownRelapsed or Refractory Multiple MyelomaChina
-
Xijing HospitalGracell Biotechnology Ltd.Unknown
-
Pharmacyclics LLC.Celgene CorporationTerminatedMultiple MyelomaUnited States, Spain, Australia, Czechia, Germany, Greece
-
CelgeneCompleted
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Poland, United Kingdom, Belgium, Spain, Germany, Portugal, Bulgaria, Romania, Netherlands, Greece, Canada, Russian Federation, Hungary, Brazil, Slovakia, Czechia
-
CelgeneCompletedMultiple MyelomaCanada, Denmark, Australia, Belgium, France, Germany, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom, Czechia, Greece
-
CelgeneCompletedMultiple MyelomaIndia, Philippines, France, Portugal, Poland, South Africa, Bulgaria, Croatia, Czechia, Germany, Hungary, Italy, Serbia, Slovakia, United Kingdom
-
Novartis PharmaceuticalsCompletedRelapse/Refractory Multiple MyelomaJapan
-
M.D. Anderson Cancer CenterDaiichi Sankyo UK Ltd.Terminated
-
CelgeneApproved for marketingMultiple MyelomaUnited States, Canada
-
CelgeneCompleted
-
CelgeneCompleted
-
Janssen Research & Development, LLCCompleted
-
Ashraf BadrosMerck Sharp & Dohme LLCTerminatedMultiple MyelomaUnited States
-
University of Maryland, BaltimoreNational Cancer Institute (NCI); University of Maryland Greenebaum Cancer CenterCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
The First Hospital of Jilin UniversityUnknownMultiple Myeloma in RelapseChina